Michal Jakub Kubiak

Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL

Ibrahim Aldoss, Gregory W. Roloff, Rawan Faramand, Noam E. Kopmar et autres

ABSTRACT: The effect of prior inotuzumab ozogamicin (InO) treatment on brexucabtagene autoleucel (brexu-cel) outcomes remains unclear in adults with acute lymphoblastic leukemia (ALL). We conducted a retrospective multicenter analysis of 189 patients with relapsed/refractory ALL treated with brexu-cel. Over half of the …

us (code pays fourni par la source)

Musculoskeletal Pain Syndrome in a Subset of APL Patients during Induction Therapy

Michal Jakub Kubiak, Anand P. Jillella, Danielle Bradshaw, Natasha M. Savage et autres

us (code pays fourni par la source)

I AM UGLY, BUT NOT CANCER: A CALCIFYING FIBROUS TUMOR IN THE CHEST

Nikita Jain, Anchit Bharat, Nadiia Marenych, Michal Jakub Kubiak et autres

Testicular Metastasis of a Upper Urinary Tract High-grade Papillary Urothelial Carcinoma, 2 Years After Nephroureterectomy

Michal Jakub Kubiak, Jacques‐Olivier Klein, Thomas de Perrot, Jean Christophe Tille et autres

Urothelial carcinomas are the fourth most common tumors in men. Upper tract urinary carcinomas (UTUCs) are uncommon and represent only 5-10% of urothelial carcinomas.(1) Metastatic testicular cancers are rare and primary tumor sources are the prostate, lung, and gastrointestinal tract. We report …

ch (code pays fourni par la source)